Lobectomy

Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs. wedge resection, according to results presented at the Society of Thoracic Surgeons Annual Meeting.

Compared with gross total resection, lobectomy as a surgical intervention for individuals with glioblastoma had a more positive impact on progression-free and overall survival outcomes, according to a systematic review and meta-analysis.

Adults who undergo thyroid cancer surgery at clinics performing five or fewer operations per year are more likely to have recurrence or persistent disease than those attending higher-volume centers, according to study data.

In this edition, lobectomy alternatives show adverse event profiles; frequent CT scans not linked to better surgery outcomes; FDA approves adjuvant Keytruda, and more.

In this video, Andrew Ciupek, PhD, discusses findings from the Alliance trial, IMpower010 and NADIM-2.

Sublobar resection conferred similar survival outcomes as lobectomy among certain patients with non-small cell lung cancer, according to phase 3 study results.

From 2000 to 2018, use of radioactive iodine therapy in papillary thyroid cancer treatment greatly declined in favor of total thyroidectomy alone without radioactive iodine or lobectomy, according to study data.

Serum thyroglobulin levels after a lobectomy can be used to predict recurrence risk for adults with papillary thyroid carcinoma, according to findings published in Thyroid.

A 61-year-old woman was referred to the New England Eye Center’s comprehensive ophthalmology service with decreased vision in the left eye.

Adults with papillary thyroid microcarcinoma may spend less time and money without sacrificing treatment benefits if they have radiofrequency ablation rather than thyroid surgery, according to findings published in Thyroid.